Lv71
3920 积分 2020-03-29 加入
加油加油加油！
Izalontamab brengitecan versus platinum-based chemotherapy in EGFR-mutated advanced non-squamous non-small-cell lung cancer after progression on third-generation EGFR tyrosine kinase inhibitors (PANKU-Lung01): a multicentre, randomised, open-label, phase 3 trial in China
40分钟前
待确认
Tepotinib plus osimertinib in patients with EGFR-mutated non-small-cell lung cancer with MET amplification following progression on first-line osimertinib (INSIGHT 2): a multicentre, open-label, phase 2 trial
3天前
已完结
Tepotinib plus osimertinib in patients with EGFR-mutated non-small-cell lung cancer with MET amplification following progression on first-line osimertinib (INSIGHT 2): a multicentre, open-label, phase 2 trial
3天前
已完结
Caudate Lobe Hepatocellular Carcinoma Treated with Selective Chemoembolization
1个月前
已完结
Nonresectable Combined Hepatocellular Carcinoma and Cholangiocarcinoma: Analysis of the Response and Prognostic Factors after Transcatheter Arterial Chemoembolization
1个月前
已完结
Interventional Oncologic Approaches to Liver Metastases
1个月前
已完结
Selective Chemoembolization of Caudate Lobe Hepatocellular Carcinoma: Anatomy and Procedural Techniques
1个月前
已完结
Beyond anatomy: tumor morphology stratifies survival after curative-intent resection of cholangiocarcinoma involving the hepatic hilum
2个月前
已关闭
NK cell tumor therapy modulated by UV-inactivated oncolytic herpes simplex virus type 2 and checkpoint inhibitors
4个月前
已完结
Influence of CT harmonization in longitudinal radiomics for NSCLC immunotherapy response prediction
4个月前
已完结
皖公网安备34019202002308
